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Cuneo, Bologna, and Milan, ItalyThe euroSCORE II has recently been developed to increase
the performance of the older versions that have been
demonstrated to be miscalibrated.1 Although the core of
the algorithm is similar, some new pieces have been added,
among them a different classification of operations and a
novel categorization of number of procedures. Nonetheless,
no data are available regarding the potential relationship
between euroSCORE II performance and surgical proce-
dures. The purpose of this study was to evaluate the impact
of surgical procedures on euroSCORE II calibration by
modeling the receiver operating characteristic (ROC) curve
with a generalized linear model.MATERIALS AND METHODS
Data on 13,871 consecutive patients who underwent cardiac surgery in a
6-year period were retrieved from the institutional databases that are
prospectively collected within the departments of cardiac surgery of two
university hospitals and one regional hospital in Italy. The relevant
institutional review boards approved the data set’s use for research. The
Institutional Ethical Committees approved the study, and the requirement
for informed written consent was waived on the condition that subjects’
identities remain masked. Data from the three centers were matched and
stored in a dedicated data set. The euroSCORE II was tested on the predic-
tion of in-hospital mortality. Discriminative power was assessed with the
c-index (area under the ROC curve [AUC]). To analyze the effect of type
of surgery on discriminative power, we modeled the ROC curve with a
parametric generalized linear model, with a binormal mode.2 Two-sided
statistics were performed. For all analyses, the R 2.15.1 softwarewas used.3RESULTS
The mean value of euroSCORE II was 3.0  4.1, and the
observed mortality was 2.5% (335 patients). The mean age
of the study group was 67.4 11.7 years, and 31.4% (4359
patients) were female. A majority of the group underwent
isolated or associated coronary artery bypass grafting
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showed a worse performance of the euroSCORE II in the
surgical subgroups not included in the algorithm, such
as aortic valve surgery, mitral valve surgery, tricuspid
valve surgery (AUC 0.80, 95% confidence interval [CI]
0.77-0.83 vs AUC 0.87, 95% CI 0.83-0.91 for procedures
included in the algorithm; Figure 1)
The multivariable direct parametric modeling of ROC
curves with generalized linear model methodology demon-
strated that surgery of the mitral valve significantly lowers
the discriminative performance of the euroSCORE II by
affecting both parameters that define the ROC curve
(intercept 0.38  0.16; 95% CI 0.68 to 0.05; slope
0.36  0.10, 95% CI 0.57 to 0.15; Table 1), leading
to a curve that is closer to the diagonal line. The effect of
other procedures is not significant, and the performances
for these subgroups of patients are comparable to that for
patients undergoing CABG.
DISCUSSION
Perioperative outcomes are known to be influenced
by several parameters, including the type of surgicalFIGURE 1. Receiver operating characteristic (ROC) curves for the Euro-
SCORE II in procedures included (CABG, surgery for aortic disease) and
not included (such as aortic valve surgery, mitral valve surgery, tricuspid
surgery) in the algorithm. The diagonal line represents no discriminatory
power (area under the receiver operating characteristic curve of 0.50).
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TABLE 1. Parameters of the receiver operating characteristic curve after generalized linear modeling
Surgical procedure Value 95% Confidence interval P value
Intercept 1.22  0.10 1.04–1.45 <.05
Slope 0.91  0.08 0.78–1.1 <.05
Effect of mitral surgery on intercept 0.38  0.16 0.68 to 0.06 <.05
Effect of mitral surgery on slope 0.36  0.10 0.57 to 0.15 <.05
Receiver operating characteristic curve is defined by 2 parameters, intercept and slope. The only covariate significantly affecting the receiver operating characteristic curve
parameters was mitral valve surgery, which negatively affected discriminative performance.
Brief Research Reportsintervention, and different surgical procedures are therefore
expected to exert different effects on the prediction of
in-hospital mortality. The Society of Thoracic Surgeons
score was developed from data from distinct surgical
populations, and the weight of procedures in risk prediction
was underscored and included in the model.4 In contrast, the
recently released euroSCORE II categorizes surgeries in
general classes, privileging the role of the number of
procedures without differentiating among non-CABG
procedures.1 In this analysis, we have demonstrated that
the discriminative performance of euroSCORE II is higher
for surgical categories included in the algorithm, such as
CABG or surgery for aortic disease, whereas it decreases
in other classes. Nonetheless, the only covariate that
significantly affects the ROC curve is surgery for mitral
disease, which decreases the performance of the score.
The discriminative power of euroSCORE II significantly
worsens when applied to mitral surgery, although it still
remains satisfactory (AUC 0.79, 95% CI 0.74-0.84).
Previous validation studies have demonstrated good
discrimination in the case of both isolated CABG and aortic
valve replacement, although no composite evaluation of all
surgical subgroups has been performed.5,6
The identification of independent predictors of discrimi-
natory accuracy should lead to covariate adjustment or to
the incorporation of such factors in the score algorithm.
Nonetheless, further studies from larger data sets are neededFrom the Lung Transplant Program, Ho^pitaux Universitaires de Strasbourg,
Strasbourg, France.
Disclosures: Authors have nothing to disclose with regard to commercial support.
Received for publication Feb 26, 2013; revisions receivedMay 16, 2013; accepted for
publication May 31, 2013; available ahead of print July 15, 2013.
Address for reprints: Anne Olland, MSc, MD, Thoracic Surgery Department,
Ho^pitaux Universitaires de Strasbourg, Nouvel Ho^pital Civil, 67091 Strasbourg
Cedex, France (E-mail: anne.olland@chru-strasbourg.fr).
J Thorac Cardiovasc Surg 2013;146:987-9
0022-5223/$36.00
Copyright  2013 by The American Association for Thoracic Surgery
http://dx.doi.org/10.1016/j.jtcvs.2013.05.046
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techniques for the same disease, because the classification
of surgeries that we tested is generic. The general category
‘‘surgery for mitral disease,’’ and also other surgical
categories, includes different treatment options that can
have an effect on outcomes.
The more complex categorization introduced in the
updated euroSCORE II to update the older versions still
seems inadequate. Further testing and refinement of the
algorithm should include further surgical categories, and
even subcategories.References
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Gilbert Massard, MD, PhD, FETS, Strasbourg, FrancePatients listed for lung transplants still suffer from lack of
available donor organs. In France between 2004 and
2009, an average of 31 patients yearly died while on the
waiting list.1 Single-lung transplants (SLTs) have the theo-
retic advantage of increasing access to transplantation by
sharing a single donor between 2 recipients who become
‘‘twinned.’’ Twinned SLTs (TSLTs) are feasible even in a
single center, without impairment of outcome in the second
recipient despite longer ischemia.2 The real benefit of TSLTrdiovascular Surgery c Volume 146, Number 4 987
